HDAC/BET-IN-1 is a dual-acting inhibitor targeting histone deacetylases (HDAC1/6) and bromodomain protein BRD4 with submicromolar potency. It demonstrates significant antileukemic activity in cellular assays, making it a valuable chemical probe for oncology research, particularly in studying epigenetic pathways and their role in hematological malignancies.
Molecular Weight:
604.71
CAS Number:
[2757573-68-3]
Formula:
C29H40N4O8S
Target:
HDAC
* VAT and and shipping costs not included. Errors and price changes excepted